you are viewing a single comment's thread.
Your numbers look optimistic, but not implausible. What they were doing in the bad call, though, was TRYING to underpromise (so they could then over deliver).
I would really seriously like to see discussion of the deep pipeline. It would be pretty bizarre to have final results of phase 2s reported with no official statements about what the drugs were for.
I agree and would love to see some discussion of the pipeline. My only guess as to why not...is they have think they are sitting on a "gold mine" and don't want competition to know until they are further along in the approval process.
Come on...any other guesses.....